Empagliflozin reduces heart failure irrespective of control of blood pressure, low density lipoprotein cholesterol and HbA1c
26 August 2017 (00:00 - 00:00)
Organised by:
About the speaker
St. Michael's Hospital, Toronto (Canada)
6 More presentations in this session
Doctor K. Ozieranski (Warsaw, PL)
Associate Professor J. Siller-Matula (Vienna, AT)
Ms L. Qin (Gaithersburg, US)
Doctor P. Jorgensen (Hellerup, DK)
Doctor J. Yap (Singapore, SG)
Access the full session
The Event
ESC Congress 2017
26 August - 30 August 2017
